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Chronic wasting disease (CWD), a member of the transmissible spongiform encephalopathies (TSEs), was first identified
in captive mule and black-tail deer in 1967. Due to the failure to transmit CWD to rodents, we investigated the use of ferrets
(Mustela putorius furo) as a small animal model of CWD. The inoculation of CWD into ferrets resulted in an incubation period
of 17–21 months on primary passage that shortened to 5 months by the third ferret passage. The brain tissue of animals
inoculated with ferret-passaged CWD exhibited spongiform degeneration and reactive astrocytosis. Western blot analysis of
ferret-passaged CWD demonstrated the presence of PrP-res. Unlike mule deer CWD, ferret-passaged CWD was transmis-
sible to Syrian golden hamsters (Mesocricetus auratus). Increasing the passage number of CWD in ferrets increased the
pathogenicity of the agent for hamsters. This increase in host range of a field isolate on interspecies transmission
emphasizes the need for caution when assessing the potential risk of transmission of TSEs, such as bovine spongiform
encephalopathy, to new host species. © 1998 Academic Press
INTRODUCTION
Chronic wasting disease (CWD) of deer and elk is a
member of the transmissible spongiform encephalopa-
thies (TSEs), a group of insidious neurological diseases
that have preclinical incubation periods of months to
years. Other animal TSEs include bovine spongiform
encephalopathy, transmissible mink encephalopathy
(TME), and scrapie of sheep and goats. In humans, the
TSEs are Creutzfeldt–Jakob disease (CJD), Gerstmann–
Stra¨ussler–Scheinker syndrome, fatal familial insomnia,
and kuru. TSEs share a common neuropathology that
includes spongiform degeneration, reactive astrocytosis,
and deposition of an abnormal isoform of the host prion
protein (PrP-res). Although the precise composition of
the TSE agent is not known, a considerable body of
evidence supports the hypothesis that the TSE agent
contains PrP-res (Prusiner, 1982).
CWD was first identified in captive mule deer and
black-tail deer in 1967 (Williams and Young, 1980) and
later in captive Rocky Mountain elk (Williams and Young,
1982). Recently, CWD has been detected in wild popula-
tions of mule deer, white-tailed deer, and Rocky Moun-
tain elk (Spraker et al., 1997). Although CWD has been
primarily identified in northcentral Colorado and south-
eastern Wyoming, whether it is limited to this geograph-
ical area or is present in other locations is unknown
(Williams and Young, 1992).
The etiology and mode of transmission of CWD are
unknown. It is unclear whether CWD is the result of the
transmission of sheep scrapie to deer and elk or represents
a naturally occurring TSE of cervids. Regardless of the
origin, CWD clearly is a self-sustaining disease. Although
CWD can be transmitted horizontally in captive populations
(Williams and Young, 1992), it is unknown whether horizon-
tal transmission occurs in wild populations.
Experimental transmission of CWD to other species has
had mixed results. CWD has been successfully transmitted
to mink, squirrel monkeys (R. F. Marsh, unpublished data),
mule deer, and a domestic goat (Williams and Young, 1992).
Multiple attempts to transmit CWD to Syrian golden ham-
sters have been unsuccessful (Williams and Young, 1992),
whereas transmission to mice is very inefficient (Williams
and Young, 1992; M. Bruce, personal communication). In
this study, we report the successful transmission of CWD of
mule deer to ferrets. The adaptation of CWD to ferrets
results in an altered host range as demonstrated by the
transmission of ferret-adapted CWD to hamsters, a host
nonpermissive to mule deer CWD.
RESULTS
Transmission studies of CWD to ferrets and hamsters
To determine the susceptibility of ferrets and hamsters
to CWD, a 10% brain homogenate from a mule deer
clinically affected with CWD from northcentral Colorado
(a gift from Dr. Beth Williams) was used to intracerebrally
inoculate 20 hamsters and eight weanling ferrets. None
of the hamsters inoculated with mule deer CWD had
developed neurological symptoms by 1 year after inoc-
ulation, at which time the experiment was terminated.
Two ferrets died at ;12 months of age from unrelated
disease. The remaining six ferrets were killed at 17–21
1 To whom reprint requests should be addressed. Fax: (608) 262-
7420. E-mail: jma@ahabs.wisc.edu.
VIROLOGY 251, 297–301 (1998)
ARTICLE NO. VY989427
0042-6822/98 $25.00
Copyright © 1998 by Academic Press
All rights of reproduction in any form reserved.
297
months after inoculation and had clinical signs of neu-
rological disease, ataxia, and lethargy, lasting 1–6 weeks
(Table 1). Serial transmission (10% w/v brain homoge-
nate) of first passage ferret CWD into 12 ferrets resulted
in 11 affected ferrets with an incubation period of 8–9
months and clinical signs lasting from 1–4 weeks (Table
1). Serial transmission of second passage CWD into five
ferrets produced disease in all animals with an incuba-
tion period of 5 months and clinical signs lasting 1–3
weeks (Table 1). Subsequent passages in ferrets did not
significantly alter the incubation period. All buffer-only
inoculated ferrets and hamsters remained asymptomatic
throughout the duration of the experiment.
Western blot analysis of CWD mule deer and ferrets
PrP-res-enriched preparations from the brain of a mule
deer infected with CWD, a ferret infected with CWD, a
ferret infected with scrapie, and a hamster infected with
Hyper-TME were analyzed by Western blot using the
polyclonal anti-mink PrP-res antibody (Fig. 1). The dis-
ease-specific isoform of PrP, PrP-res, is present in both
the CWD-infected mule deer and ferrets. The polyclonal
anti-mink PrP-res antibody recognizes mule deer and
ferret PrP-res but not hamster PrP-res (Fig. 1).
Histology of CWD ferrets
Hematoxylin–eosin-stained sections from the brain of
CWD-infected ferrets demonstrated extensive spongiform
degeneration that was mainly observed in the gray matter
neuropil of multiple regions of the brains of ferrets affected
with CWD (Fig. 2A). This phenomenon was accompanied
by a reactive astrocytosis as determined by immunohisto-
chemistry for the astrocyte-specific protein glial fibrillary
acidic protein (Fig. 2B). Unlike mule deer and elk CWD
(Williams and Young, 1993), we observed no amyloid
plaques in CWD-infected ferret brain.
Transmission of ferret-adapted CWD to hamsters
To investigate the effect that interspecies transmission
may have on TSE agent host range, we inoculated ham-
sters with ferret-passaged CWD. Both second and fourth
passage ferret-adapted CWD was examined for patho-
genicity in hamsters. Of the 24 hamsters inoculated with
second ferret-passaged CWD, two hamsters developed
a progressive neurological disorder at 132 days after
inoculation, and a third hamster developed similar symp-
toms at 187 days after inoculation (Fig. 3). The remaining
21 hamsters inoculated with second ferret-passaged
CWD, as well as the mock-inoculated controls, were
asymptomatic at 400 days after inoculation (Fig. 3). The
inoculation of fourth ferret-passaged CWD into 20 Syrian
golden hamsters resulted in 16 hamsters developing a
progressive neurological disorder at 152 6 44 days after
infection. The onset of clinical symptoms ranged from
100–239 days after inoculation (Fig. 3). The remaining
four hamsters, in addition to the mock-inoculated con-
trols, were asymptomatic at 300 days after inoculation
(Fig. 3). A 10% brain homogenate from a hamster that
developed clinical symptoms on day 132 was used to
inoculate 14 Syrian hamsters. All 14 hamsters developed
a progressive neurological disorder characterized by hy-
perexcitability and ataxia at 53 days after inoculation. A
10% brain homogenate from a second passage hamster
was inoculated into 10 Syrian hamsters, resulting in all
10 of the hamsters developing hyperexcitability and
ataxia at 50 6 2 (days 6 SEM) after inoculation.
A 10% brain homogenate from a hamster that devel-
oped clinical symptoms at 107 days after inoculation was
used to inoculate 22 Syrian hamsters. All of these ham-
sters developed a progressive neurological disorder
characterized by hyperexcitability and ataxia at 56 6 2
days after inoculation. A 10% brain homogenate from a
pool of three of the second passage hamsters was used
to inoculate 30 Syrian hamsters. All 30 hamsters devel-
oped hyperexcitability and ataxia at 58 6 4 days.
Western blot analysis of hamsters infected with
ferret-passaged CWD
Western blot analysis was used to assay for the pres-
ence of PrP-res in hamsters inoculated with second and
FIG. 1. Western blot analysis of mule deer CWD and ferret-adapted
CWD PrP-res. PrP-res-enriched preparations from a CWD-infected
mule deer (CWD MD), a CWD-infected ferret (CWD Ft), a scrapie-
infected ferret (SCR Ft), and a hamster infected with the Hyper strain of
TME (HY Ha) were analyzed by Western blotting using an anti-mink
PrPTME antibody. The positions of the 29- and 20-kDa molecular weight
markers are indicated (left).
TABLE 1
Affected Animals and Incubation Period
Passage
no.
No. affected/no.
inoculated
Incubation
period (mo)
1 6/8a 17–21
2 11/12 8–9
3 5/5 5
a Two intercurrent deaths.
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fourth ferret-passaged CWD. Whole brain homogenates
(5 ml of a 10% homogenate) of the hamster passages
were analyzed by Western blot using the 3F4 antibody
indicated the presence of PrP-res (Fig. 4).
DISCUSSION
CWD is an emerging TSE originally recognized in captive
mule deer and elk (Williams and Young, 1992, 1993), which
has also been recently identified in wild populations
(Spraker et al., 1997). The identification of a small animal
model of CWD is essential for the characterization of this
TSE. Due to the inability to transmit CWD to rodents, we
examined the susceptibility of ferrets to CWD. We found
CWD to be readily transmitted to ferrets, thus providing a
useful animal model for future CWD transmission studies.
Interspecies transmission of TSEs has received height-
ened interest in recent years due to the bovine spongiform
encephalopathy (BSE) epizootic in Great Britain. BSE has
been demonstrated to be experimentally transmissible to
numerous species, including sheep, mice, pigs, and mon-
FIG. 2. Histopathology of ferret-adapted CWD. Representative spongiform degeneration (A, hematoxylin and eosin) and reactive astrocytosis (B)
(GFAP immunohistochemistry) in the posterior sigmoidal gyrus of ferrets inoculated with ferret-passaged CWD. (Scale bar 5 50 mm).
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keys (Bradley, 1996), and there is increasing evidence that
BSE has been transmitted to humans in the form of new
variant CJD (Bruce et al., 1997; Will et al., 1996). It is sus-
pected that BSE originated from the transmission of scrapie
into cattle and that once adapted to cattle, the agent exhib-
ited an altered host range.
Experimental interspecies transmission of the TSE agent
often results in modification of the agent strain properties
but does not alter the host range of the agent because
there are very few hosts that are resistant to infection
(Bessen and Marsh, 1992; Kimberlin and Walker, 1977,
1978). There are a few examples, however, of species that
are resistant to infection by specific strains of the TSE
agent. Although hamsters are not susceptible to bovine-
passaged goat scrapie, they are, however, susceptible to
this agent after passage in mice (Gibbs et al., 1997), dem-
onstrating that interspecies transmission has increased the
host range of the agent to include a species that it was not
originally able to infect.
Mule deer CWD has not been successfully transmitted
to hamsters (Williams and Young, 1992). Hamsters can,
however, be infected with ferret-passaged CWD (Figs. 3
and 5), demonstrating that passage of CWD in ferrets
expands the agent’s host range. The passage of CWD in
ferrets provides an example of an expansion of TSE
agent host tropism due to passage history. Interestingly,
further passage in ferrets increases the pathogenicity for
hamsters, indicating selection of an TSE agent strain that
is more readily able to infect and/or produce disease in
hamsters (Fig. 3). It is unlikely that the ferret-adapted
CWD strain, which is pathogenic for hamsters, was
present in the original CWD mule deer brain because
this inoculum is unable to infect hamsters, suggesting
that the strain pathogenic for hamsters arose early in the
ferret passage history.
In this study, we experimentally expanded the host
range of the CWD agent to include the ferret, an animal
that can serve as a useful model for future CWD trans-
mission studies. Furthermore, we demonstrate that inter-
species transmission of CWD to ferrets expands the
agent tropism of this field isolate to include a previously
resistant species (the hamster). These data illustrate the
caution that must be used when host range predictions
are based on the characteristics of the originating TSE.
MATERIALS AND METHODS
Bioassay
Weanling ferrets (Mustela putorius furo) or Syrian
golden hamsters (Mesocricetus auratus) were inocu-
lated intracerebrally with 30 ml of a 10% w/v brain ho-
mogenate (CWD mule deer, CWD ferret, or CWD ham-
ster) in PBS. Brain homogenates were prepared with
disposable syringes in disposable plasticware. Control
animals were inoculated with buffer alone. Hamsters
were housed in new boxes and racks in an animal room
that had not been previously used for TSE bioassays. All
animals were observed daily for the onset of neurologi-
cal disease. The date of the second positive scoring for
neurological disease was used to calculate the incuba-
tion period. Animals were killed by CO2 asphyxiation, and
brain tissue was removed with new instruments for fur-
ther analysis.
PrP-res-enriched preparations
An equal volume of 20% N-lauroyl-sarcosine (Sigma)
was added to 600 ml of 10% brain homogenate, vortexed,
and incubated for 30 min at room temperature. The
FIG. 3. Interspecies transmission of ferret-adapted CWD to Syrian
hamsters. The points represent time to onset of clinical disease in
hamsters inoculated intracerebrally with 30 ml of a 10% brain homog-
enate from second ferret-passaged and fourth ferret-passaged CWD.
Inoculum, second ferret-passaged CWD (dotted and dashed line),
fourth ferret-passaged (dashed line), or buffer alone (solid line).
FIG. 4. Western blot analysis of PrP-res from CWD-infected hamsters.
PK-treated brain homogenates (5 ml of 10% w/v) of the first three
hamster passages of second and fourth ferret-passaged CWD were
analyzed by Western blot with the 3F4 antibody. The position of the
29-kDa molecular weight marker is indicated (left).
FIG. 5. CWD transmission summary. Mule deer CWD is unable to
infect Syrian golden hamsters (A). Passage of mule deer CWD through
ferrets (B) modifies tropism of the CWD agent, expanding the host
range and allowing for infection of hamsters (C).
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mixture was centrifuged at 19,000 rpm in a TLA-45 rotor
(Beckman) for 30 min at 20°C. The supernatant (1 ml)
was removed and centrifuged at 45,000 rpm in a TLA-45
rotor (Beckman) for 60 min at 20°C, and the resulting
pellet was resuspended in 100 ml of PBS. The samples
were sonicated in a cup-horn sonicator (Fisher) for 1 min
and stored at 220°C until use.
Western blot analysis
Brain homogenates (5 ml of 10%) or PrP-res-enriched
preparations (10-mg brain equivalents) were digested
with 50 mg/ml Proteinase K (Boehringer-Mannheim) for
30 min at 37°C. The samples were size fractionated on
15% SDS–PAGE, transferred to Immobilon P (Millipore)
using a semidry (Hoefer) apparatus, and incubated with
polyclonal hamster anti-mink PrP antibody (1:500) for
16 h at room temperature. The membrane was washed
(50 mM Tris, pH 7.4, 150 mM NaCl, 1 mM EDTA, 0.05%
Tween 20) and incubated with anti-hamster IgG-AP (1:
1000; Kirkegaard and Perry). The membrane was then
washed and developed with 50 mg/ml nitro blue tetrazo-
lium chloride and 100 mg/ml 5-bromo-4-chloro-3-indolyl
phosphate in developing buffer (50 mM Tris, pH 9.5, 3
mM MgCl2).
Antibody preparation
The brain of a mink clinically affected with TME was
homogenized to 10% (w/v) in Tris-buffered saline (TBS)
and centrifuged at 5000 g for 3 min in a TLA-45 rotor at
4°C. The supernatant was discarded, and the pellet (P1)
was resuspended in 500 ml of TBS and centrifuged at
5000 g for 3 min in a TLA-45 rotor at 4°C. The resulting
pellet (P2) was saved, and the supernatant was recen-
trifuged at 20,000 g for 40 min at 4°C. The supernatant
was removed and discarded, and the pellet (P3) was
saved. The P2 and P3 pellets were combined and treated
with 99% formic acid (Sigma) for 2 h on ice. After evap-
oration of the formic acid, 1 ml of TBS containing 0.1%
Nonidet P-40 was added. The antigen was emulsified
with complete Freund’s adjuvant (Bacto) before immuni-
zation. Syrian golden hamsters were injected with 200 ml
of the antigen i.p. and 150 ml i.m. Hamsters were boosted
by i.p. injection of 200 ml of antigen 1 month after the
primary immunization. Blood was collected from the
hamsters by cardiac puncture and incubated at 37°C for
1 h followed by 16 h at 4°C. The blood clot was removed,
and the serum was centrifuged (2000 g) for 10 min. The
supernatant was transferred and stored at 280°C.
Histology
Brain tissue was fixed in Formalin, embedded in par-
affin, sectioned (8 mm), and stained with hematoxylin–
eosin. For immunohistochemical analysis, unstained
slides were deparaffinized with xylene and rehydrated in
a 100–70% ethanol gradient with a final incubation in
water before incubation with a rabbit anti-cow GFAP
(DAKO; 1:1000 dilution) primary antibody in 0.1% goat
serum in TBS with 0.1% Tween 20. Biotinylated anti-rabbit
IgG secondary antibody and Vectastain ABC reagent
(Vector Labs, Burlingame, CA) were used according to
manufacturer’s instructions. Immunoreactivity was devel-
oped with 0.5% 3,39-diaminobenzidine and 0.03% H2O2.
Slides were counterstained with Mayer’s hematoxylin
and mounted in Permount.
ACKNOWLEDGMENTS
We would like to thank Dr. Beth Williams for providing the CWD mule
deer tissue. This work is supported by U.S. Department of Agriculture
Grant 95–37204-2238 and National Institutes of Health Grant R01-
AG10669.
REFERENCES
Bessen, R. A., and Marsh, R. M. (1992). Identification of two biologically
distinct strains of transmissible mink encephalopathy in hamsters.
J. Gen. Virol. 73, 329–334.
Bradley, R. (1996). Bovine spongiform encephalopathy distribution and
update on some transmission and decontamination studies. In ’’Bo-
vine Spongiform Encephalopathy: The BSE Dilemma’’ (C. Gibbs, ed.),
pp. 11–27. Springer, New York.
Bruce, M. E., Will, R. G., Ironside, J. W., McConnell, I., Drummond, D.,
Suttie, A., McCardle, L., Chree, A., Hope, J., Birkett, C., Cousens, S.,
Fraser, H., and Bostock, C. J. (1997). Transmissions to mice indicate
that ’new variant’ CJD is caused by the BSE agent. Nature 389,
498–501.
Gibbs, C. J., Safar, J., Sulima, M. P., Bacate, A. E., and San Martin, R. A.
(1996). Transmission of sheep and goat strains of scrapie from
experimentally infected cattle to hamsters and mice. In ’’Bovine
Spongiform Encephalopathy: The BSE Dilemma’’ (C. Gibbs, ed.), pp.
84–91. Springer, New York.
Kimberlin, R. H., and Walker, C. A. (1977). Characteristics of a short
incubation model of scrapie in the golden hamster. J. Gen. Virol. 34,
295–304.
Kimberlin, R. H., and Walker, C. A. (1978). Evidence that the transmis-
sion of one source of scrapie agent to hamsters involves separation
of agent strains from a mixture. J. Gen. Virol. 39, 487–496.
Prusiner, S. B. (1982). Novel proteinaceous infectious particles cause
scrapie. Science 216, 136–144.
Spraker, T. R., Miller, M. W., Williams, E. S., Getzy, D. M., Adrian, W. J.,
Schoonveld, G. G., Spowart, R. A., O’Rourke, K. I., Miller, J., and Merz,
P. A. (1997). Spongiform encephalopathy in free-ranging mule deer
(Odocoileus hemionus), white-tailed deer (Odocoileus virginianus)
and Rocky Mountain elk (Cervus elaphys nelsoni) in northcentral
Colorado. J. Wildlife Dis. 33, 1–6.
Will, R. G., Ironside, J. W., Zeidler, M., Cousens, S. N., Estibeiro, K.,
Alperovitch, A., Poser, S., Pocchiari, M., Hofman, A., and Smith, P. G.
(1996). A new variant of the Creutzfeldt-Jakob disease in the UK.
Lancet 347, 921–925.
Williams E. S., and Young, S. (1980). Chronic wasting disease of captive
mule deer: A spongiform encephalopathy. J. Wildlife Dis. 16, 89–98.
Williams, E. S., and Young, S. (1982). Spongiform encephalopathy of
Rocky Mountain elk. J. Wildlife Dis. 18, 465–471.
Williams, E. S., and Young, S. (1992). Spongiform encephalopathies in
Cervidae. Rev. Sci. Tech. 11, 551–567.
Williams, E. S., and Young, S. (1993). Neuropathology of chronic wasting
disease of mule deer (Odocoileus hemionus) and elk (Cervus ela-
phus nelsoni). Vet. Pathol. 30, 36–45.
301HOST RANGE OF CHRONIC WASTING DISEASE
